Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
SyneuRx Announces Oral COVID-19 Twindemic Antiviral Drug Candidate Pentarlandir Has Entered Final Portion of FDA Phase II Testing 2021-11-20 01:00
1